182 related articles for article (PubMed ID: 18728247)
1. Clinical and immunologic consequences of a somatic reversion in a patient with X-linked severe combined immunodeficiency.
Speckmann C; Pannicke U; Wiech E; Schwarz K; Fisch P; Friedrich W; Niehues T; Gilmour K; Buiting K; Schlesier M; Eibel H; Rohr J; Superti-Furga A; Gross-Wieltsch U; Ehl S
Blood; 2008 Nov; 112(10):4090-7. PubMed ID: 18728247
[TBL] [Abstract][Full Text] [Related]
2. Targeted genome editing restores T cell differentiation in a humanized X-SCID pluripotent stem cell disease model.
Alzubi J; Pallant C; Mussolino C; Howe SJ; Thrasher AJ; Cathomen T
Sci Rep; 2017 Sep; 7(1):12475. PubMed ID: 28963568
[TBL] [Abstract][Full Text] [Related]
3. A synonymous splice site mutation in IL2RG gene causes late-onset combined immunodeficiency.
Yamashita M; Wakatsuki R; Kato T; Okano T; Yamanishi S; Mayumi N; Tanaka M; Ogura Y; Kanegane H; Nonoyama S; Imai K; Morio T
Int J Hematol; 2019 May; 109(5):603-611. PubMed ID: 30850927
[TBL] [Abstract][Full Text] [Related]
4. A novel common gamma chain mutation in a Chinese family with X-linked severe combined immunodeficiency (X-SCID; T(-)NK(-)B(+)).
Tan W; Yu S; Lei J; Wu B; Wu C
Immunogenetics; 2015 Nov; 67(11-12):629-39. PubMed ID: 26409833
[TBL] [Abstract][Full Text] [Related]
5. Case Report: A Novel IL2RG Frame-Restoring Rescue Mutation Mimics Early T Cell Engraftment Following Haploidentical Hematopoietic Stem Cell Transplantation in a Patient With X-SCID.
Steininger J; Leiss-Piller A; Geier CB; Rossmanith R; Elfeky R; Bra D; Pichler H; Lawitschka A; Zubarovskaya N; Artacker G; Matthes-Leodolter S; Eibl MM; Wolf HM
Front Immunol; 2021; 12():644687. PubMed ID: 33959125
[TBL] [Abstract][Full Text] [Related]
6. Novel IL2RG Mutation Causes Leaky TLOWB+NK+ SCID With Nodular Regenerative Hyperplasia and Normal IL-15 STAT5 Phosphorylation.
Neves JF; Martins C; Cordeiro AI; Neves C; Plagnol V; Curtis J; Fabre M; Bibi S; Borrego LM; Moshous D; Nejentsev S; Gilmour K
J Pediatr Hematol Oncol; 2019 May; 41(4):328-333. PubMed ID: 29939941
[TBL] [Abstract][Full Text] [Related]
7. Detection of T lymphocytes with a second-site mutation in skin lesions of atypical X-linked severe combined immunodeficiency mimicking Omenn syndrome.
Wada T; Yasui M; Toma T; Nakayama Y; Nishida M; Shimizu M; Okajima M; Kasahara Y; Koizumi S; Inoue M; Kawa K; Yachie A
Blood; 2008 Sep; 112(5):1872-5. PubMed ID: 18559672
[TBL] [Abstract][Full Text] [Related]
8. Multiple reversions of an IL2RG mutation restore T cell function in an X-linked severe combined immunodeficiency patient.
Kawai T; Saito M; Nishikomori R; Yasumi T; Izawa K; Murakami T; Okamoto S; Mori Y; Nakagawa N; Imai K; Nonoyama S; Wada T; Yachie A; Ohmori K; Nakahata T; Heike T
J Clin Immunol; 2012 Aug; 32(4):690-7. PubMed ID: 22460439
[TBL] [Abstract][Full Text] [Related]
9. Somatic Reversion of a Novel
Hou Y; Gratz HP; Ureña-Bailén G; Gratz PG; Schilbach-Stückle K; Renno T; Güngör D; Mader DA; Malenke E; Antony JS; Handgretinger R; Mezger M
Genes (Basel); 2021 Dec; 13(1):. PubMed ID: 35052377
[TBL] [Abstract][Full Text] [Related]
10. Patients with T⁺/low NK⁺ IL-2 receptor γ chain deficiency have differentially-impaired cytokine signaling resulting in severe combined immunodeficiency.
Fuchs S; Rensing-Ehl A; Erlacher M; Vraetz T; Hartjes L; Janda A; Rizzi M; Lorenz MR; Gilmour K; de Saint-Basile G; Roifman CM; Cheuk S; Gennery A; Thrasher AJ; Fuchs I; Schwarz K; Speckmann C; Ehl S
Eur J Immunol; 2014 Oct; 44(10):3129-40. PubMed ID: 25042067
[TBL] [Abstract][Full Text] [Related]
11. Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1.
Mamcarz E; Zhou S; Lockey T; Abdelsamed H; Cross SJ; Kang G; Ma Z; Condori J; Dowdy J; Triplett B; Li C; Maron G; Aldave Becerra JC; Church JA; Dokmeci E; Love JT; da Matta Ain AC; van der Watt H; Tang X; Janssen W; Ryu BY; De Ravin SS; Weiss MJ; Youngblood B; Long-Boyle JR; Gottschalk S; Meagher MM; Malech HL; Puck JM; Cowan MJ; Sorrentino BP
N Engl J Med; 2019 Apr; 380(16):1525-1534. PubMed ID: 30995372
[TBL] [Abstract][Full Text] [Related]
12. Partial T cell defects and expanded CD56
Cifaldi C; Cotugno N; Di Cesare S; Giliani S; Di Matteo G; Amodio D; Piano Mortari E; Chiriaco M; Buonsenso D; Zangari P; Pagliara D; Gaspari S; Carsetti R; Palma P; Finocchi A; Locatelli F; Rossi P; Doria M; Cancrini C
J Leukoc Biol; 2020 Aug; 108(2):739-748. PubMed ID: 32392633
[TBL] [Abstract][Full Text] [Related]
13. A novel deletion mutation in IL2RG gene results in X-linked severe combined immunodeficiency with an atypical phenotype.
Mou W; He J; Chen X; Zhang H; Ren X; Wu X; Ni X; Xu B; Gui J
Immunogenetics; 2017 Jan; 69(1):29-38. PubMed ID: 27566612
[TBL] [Abstract][Full Text] [Related]
14. Faster T-cell development following gene therapy compared with haploidentical HSCT in the treatment of SCID-X1.
Touzot F; Moshous D; Creidy R; Neven B; Frange P; Cros G; Caccavelli L; Blondeau J; Magnani A; Luby JM; Ternaux B; Picard C; Blanche S; Fischer A; Hacein-Bey-Abina S; Cavazzana M
Blood; 2015 Jun; 125(23):3563-9. PubMed ID: 25869287
[TBL] [Abstract][Full Text] [Related]
15. T
Stepensky P; Keller B; Shamriz O; von Spee-Mayer C; Friedmann D; Shadur B; Unger S; Fuchs S; NaserEddin A; Rumman N; Amro S; Molho Pessach V; Abuzaitoun O; Somech R; Elpeleg O; Ehl S; Warnatz K
J Clin Immunol; 2018 May; 38(4):527-536. PubMed ID: 29948574
[TBL] [Abstract][Full Text] [Related]
16. A novel IL2RG mutation presenting with atypical T(-)B(+)NK+ phenotype: rapid elucidation of NK cell origin.
Estévez OA; Ortega C; Fernández S; Aguado R; Rumbao J; Perez-Navero J; Santamaría M
Pediatr Blood Cancer; 2014 Jan; 61(1):178-9. PubMed ID: 23940110
[No Abstract] [Full Text] [Related]
17. Novel Hemizygous IL2RG p.(Pro58Ser) Mutation Impairs IL-2 Receptor Complex Expression on Lymphocytes Causing X-Linked Combined Immunodeficiency.
Tuovinen EA; Grönholm J; Öhman T; Pöysti S; Toivonen R; Kreutzman A; Heiskanen K; Trotta L; Toiviainen-Salo S; Routes JM; Verbsky J; Mustjoki S; Saarela J; Kere J; Varjosalo M; Hänninen A; Seppänen MRJ
J Clin Immunol; 2020 Apr; 40(3):503-514. PubMed ID: 32072341
[TBL] [Abstract][Full Text] [Related]
18. Late-Onset Combined Immunodeficiency with a Novel IL2RG Mutation and Probable Revertant Somatic Mosaicism.
Okuno Y; Hoshino A; Muramatsu H; Kawashima N; Wang X; Yoshida K; Wada T; Gunji M; Toma T; Kato T; Shiraishi Y; Iwata A; Hori T; Kitoh T; Chiba K; Tanaka H; Sanada M; Takahashi Y; Nonoyama S; Ito M; Miyano S; Ogawa S; Kojima S; Kanegane H
J Clin Immunol; 2015 Oct; 35(7):610-4. PubMed ID: 26407811
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Expanded Gamma Delta T Cells from Atypical X-SCID Patient Reveals Preserved Function and IL2RG-Mediated Signaling.
Tuovinen EA; Pöysti S; Hamdan F; Le KM; Keskitalo S; Turunen T; Minier L; Mamia N; Heiskanen K; Varjosalo M; Cerullo V; Kere J; Seppänen MRJ; Hänninen A; Grönholm J
J Clin Immunol; 2023 Feb; 43(2):358-370. PubMed ID: 36260239
[TBL] [Abstract][Full Text] [Related]
20. The IL-2RG R328X nonsense mutation allows partial STAT-5 phosphorylation and defines a critical region involved in the leaky-SCID phenotype.
Arcas-García A; Garcia-Prat M; Magallón-Lorenz M; Martín-Nalda A; Drechsel O; Ossowski S; Alonso L; Rivière JG; Soler-Palacín P; Colobran R; Sayós J; Martínez-Gallo M; Franco-Jarava C
Clin Exp Immunol; 2020 Apr; 200(1):61-72. PubMed ID: 31799703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
